m+Medelevator.RU
← Поиск публикаций
Cureus · 2026

Vaginal Perforations After Fecal Management System Use in Critically Ill Patients: A Case Series.

Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Sebastian Sarah V, Jenkins Nicole P, Chan Amber W, Sansone Stephanie A, Smilen Scott

Аннотация

Fecal incontinence is a relatively common condition in patients admitted to the intensive care unit (ICU). Fecal management systems (FMS) were developed to divert stool away from the skin. While they have benefits, rare but serious complications can occur. This case series discusses two cases of vaginal perforations following FMS use in critically ill patients. An 87-year-old female was admitted twice to the ICU for infective endocarditis and bacterial pneumonia. During her second ICU stay, an FMS device was in place for up to 19 days, after which a vaginal perforation with stool leakage from the vagina was noted. In the second case, a 34-year-old female was admitted following disseminated intravascular coagulation (DIC) from a likely amniotic fluid embolism. An FMS was in situ for four days before a vaginal perforation, with stool leakage from the vagina, occurred. In both cases, neither patient was stable for an exam under anesthesia with possible repair, and therefore conservative management was pursued. Vaginal perforations can occur with FMS, and healthcare workers should be aware of this possible complication. Critically ill patients are at greater risk due to comorbid conditions that may impair tissue integrity, lead to possible fistula formation, and impede successful repair. While currently not listed in manufacturer guidelines, coagulopathies, including DIC, may be considered a relative contraindication for FMS use. Like other medical devices, FMS should be monitored for correct indication and proper placement and be regularly reassessed.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты